PDF(872 KB)
PDF(872 KB)
PDF(872 KB)
47例不明原因婴儿期癫癎性脑病的基因突变分析
Gene mutations in unexplained infantile epileptic encephalopathy: an analysis of 47 cases
目的 探讨不明原因婴儿期癫癎性脑病（EE）的基因突变特点。方法 以47例不明原因婴儿期EE患儿为研究对象，利用二代测序技术对所有患儿及其父母进行基因突变分析。结果 47例患儿中23例检出基因突变，其中13例为新发突变、10例为父亲或母亲存在杂合突变。23例基因突变阳性患儿中，17例检出EE相关基因突变（14例为离子通道类基因突变），2例检出先天性遗传代谢病相关基因突变，2例检出脑结构异常相关基因突变，2例检出精神智力发育迟滞相关基因突变。结论 婴儿期EE可能存在基因突变，以离子通道类基因突变为主。
Objective To investigate the characteristics of gene mutations in unexplained infantile epileptic encephalopathy (EE).Methods A total of 47 infants with unexplained infantile EE were enrolled, and next-generation sequencing was used to analyze gene mutations in these infants and their parents.Results Of all 47 infants, 23 were found to have gene mutations, among whom 13 had de novo mutations and 10 had heterozygous mutations inherited from their father or mother. Among the 23 infants with gene mutations, 17 were found to have the gene mutations related to EE (among whom 14 had ion channel gene mutations), 2 had the gene mutations related to congenital inherited metabolic diseases, 2 had the gene mutations related to brain structural abnormality, and 2 had the gene mutations related to mental retardation.Conclusions Unexplained infantile EE may have gene mutations, mainly ion channel gene mutations.
Epileptic encephalopathy / Gene mutation / Next-generation sequencing / Infant
[1] Engel J Jr, International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:report of the ILAE task force on classification and terminology[J]. Epilepsia, 2001, 42(6):796-803.
[2] Hildebrand MS, Dahl HH, Damiano JA, et al. Recent advances in the molecular genetics of epilepsy[J]. J Med Genet, 2013, 50(5):271-279.
[3] Thomas RH, Berkovic SF. The hidden genetics of epilepsy-a clinically important new paradigm[J]. Nat Rev Neurol, 2014, 10(5):283-292.
[4] Nordli DR Jr. Epileptic encephalopathies in infants and children[J]. J Clin Neurophysiol, 2012, 29(5):420-424.
[5] Helbig I, Tayoun AA. Understanding genotypes and phenotypes in epileptic encephalopathies[J]. Mol Syndromol, 2016, 7(4):172-181.
[6] Scheffer IE. Epilepsy genetics revolutionizes clinical practice[J]. Neuropediatrics, 2014, 45(2):70-74.
[7] Kong W, Zhang Y, Gao Y, et al. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disibilities[J]. Epilepsia, 2015, 56(3):431-438.
[8] 马玉平, 彭镜, 王颖, 等. 60例不明原因早期癫癎性脑病临床特点及全基因组拷贝数变异分析[J],中国当代儿科杂志, 2014, 16(11):1100-1104.
[9] Martin HC, Kim GE, Pagnamenta AT, et al. Clinical whole-genome sequenceing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis[J]. Hum Mol Genet, 2014, 23(12):3200-3211.
[10] Schnekenberg RP, Németh AH. Next-generation sequencing in childhood disorders[J]. Arch Dis Child, 2014, 99(3):284-290.
[11] Zhang Q, Li J, Zhao Y, et al. Gene mutation analysis of 175 Chinese patients with early-onset epileptic encephalopathy[J]. Clin Genet, 2017, 91(5):717-724.
[12] Gokben S, Onay H, Yilmaz S, et al. Targeted next generation sequencing:the diagnostic value in early-onset epileptic encephalopathy[J]. Acta Neurol Belg, 2017, 117(1):131-138.
[13] Dravet C. The core Dravet syndrome phenotype[J]. Epilepsia, 2011, 52(Suppl 2):3-9.
[14] Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females[J]. PLoS Genet, 2009, 5(2):e1000381.
[15] Gataullina S, Dulac O. From genotype to phenotype in Dravet disease[J]. Seizure, 2017, 44:58-64.
[16] Wang Y, Du X, Bin R, et al. Genetic variants identified from epilepsy of unknown etiology in Chinese children by targeted exome sequencing[J]. Sci Rep, 2017, 7:40319.
[17] Epi4K and EPGP Investigators. De novo mutations in the classic epileptic encephalopathies[J]. Nature, 2013, 501(7466):217-221.
[18] Kodera H, Nakamura K, Osaka H, et al. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy[J]. Hum Mutat, 2013, 34(12):1708-1714.
[19] Leuzzi V, Mastrangelo M, Battini R, et al. Inborn errors of creatine metabolism and epilepsy[J]. Epilepsia, 2013, 54(2):217-227.
[20] Berryer MH, Hamdan FF, Klitten LL, et al. Mutations in SYNGAP1 cause intellectual disability, autism and a specific form of epilepsy by inducing haploinsufficiency[J]. Hum Mutat, 2013, 34(2):385-394.
[21] Carvill GL, Heavin SB, Yendle SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1[J]. Nat Genet, 2013, 45(7):825-830.
[22] Van Maldergem L, Hou Q, Kalscheuer VM, et al. Loss of function of KIAA2022 causes mild to severe intellectual disability with an autism sepectrum disorder and impairs neurite outgrowth[J]. Hum Mol Genet, 2013, 22(16):3306-3314.
[23] de Lange IM, Helbig KL, Weckhuysen S, et al. De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy[J]. J Med Genet, 2016, 53(12):850-858.
